TDP-43 inhibitors (Aquinnah)

N/A

Report date: 2025/03/20 09:55:23
NME

Base Information

Drug NameTDP-43 inhibitors (Aquinnah)
Drug Alias NameTDP-43 inhibitors (Boston University School of Medicine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTAR DNA binding protein 43 inhibitors
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoston University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesAquinnah Pharmaceuticals Inc
Inactive CompaniesBoston University School of Medicine
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A